Physician profile
Jonathan W Shum
NPI 1518110329
$10,341.56
in general payments reported to CMS, 2019-2025
17 companies · $1,527 in 2025
The $1,527 reported for 2025 was more than what 86% of Oral & Maxillofacial Surgery providers received nationally (typical 2025 total: $184).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $821 · 2020: $2,987 · 2021: $813 · 2022: $1,521 · 2023: $933 · 2024: $1,741 · 2025: $1,527.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,199.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $2,340.00 | 2020 | |
| Kls-Martin L.P. | $2,289.52 | 2019-2025 | |
| Axogen | $2,104.25 | 2019-2025 | Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector |
| Depuy Synthes Sales INC. | $1,120.50 | 2019-2024 | Na, Matrixmandible, Trumatch |
| Stryker Corporation | $830.78 | 2019-2025 | Na, Vsp System, Vsp Cranial, Smartlock |
| Acera Surgical, INC. | $624.64 | 2024-2025 | Restrata Wound Matrix |
| Integra Lifesciences Corporation | $416.46 | 2020-2022 | |
| Zimmer Biomet Holdings, INC. | $256.90 | 2019-2020 | |
| Kerecis Limited | $102.35 | 2023-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Ethicon US, LLC | $74.04 | 2025 | Surgicel Nu-Knit, Stratafix, Vistaseal |
| Checkpoint Surgical, INC | $60.48 | 2019-2023 | Checkpoint Stimulators |
| Tempus Ai, INC | $24.20 | 2025 | Xt Cdx |
| Davol INC. | $24.15 | 2024 | Arista Ah Flexitip |
| 3d Systems | $22.83 | 2021 | |
| Nobel Biocare USA | $20.50 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acell, INC. | $16.79 | 2020 | |
| Biotissue Holdings INC. | $13.17 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Shum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.